Journal
JOURNAL OF IMMUNOLOGY
Volume 186, Issue 4, Pages 1899-1903Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1003642
Keywords
-
Categories
Funding
- Institut Pasteur
- INSERM
- Agence Nationale de la Recherche [05-JCJC-0236-01, 09-GENO-014-01]
- European Union [LSHG-CT-2005-005203]
- Fondation pour la Recherche Medicale
Ask authors/readers for more resources
K/BxN serum-induced passive arthritis was reported to depend on the activation of mast cells, triggered by the activating IgG receptor Fc gamma RIIIA, when engaged by IgG1 autoantibodies present in K/BxN serum. This view is challenged by the fact that Fc gamma RIIIA-deficient mice still develop K/BxN arthritis and because Fc gamma RIIIA is the only activating IgG receptor expressed by mast cells. We investigated the contribution of IgG receptors, IgG subclasses, and cells in K/BxN arthritis. We found that the activating IgG2 receptor Fc gamma RIV, expressed only by monocytes/macrophages and neutrophils, was sufficient to induce disease. K/BxN arthritis occurred not only in mast cell-deficient W-sh mice, but also in mice whose mast cells express no activating IgG receptors. We propose that at least two autoantibody isotypes, IgG1 and IgG2, and two activating IgG receptors, Fc gamma RIIIA and Fc gamma RIV, contribute to K/BxN arthritis, which requires at least two cell types other than mast cells, monocytes/macrophages, and neutrophils. The Journal of Immunology, 2011, 186: 1899-1903.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available